Director of Regenerative Pain Therapies
Duke University
Chapel Hill, North Carolina, United States
Dr. Buchheit is the Director of the Regenerative Pain Therapies Program at the Duke Center for Translational Pain Medicine (CTPM). His clinical practice focuses on biologically based therapies for osteoarthritis, musculoskeletal disorders, and nerve injury. His research focuses on the immunologic mechanisms that drive tissue damage and the chronification of pain. Dr. Buchheit is the ASRA Regenerative Medicine SIG Vice Chair. He previously served as Division Chief for Pain Medicine in the Duke Department of Anesthesiology (2013-2019).
WS-01 - Musculoskeletal Diagnostic Ultrasound - Upper Extremity/Trunk
Thursday, November 21, 2024
8:15 AM - 9:45 AM PT
Disclosure(s): Bull Publishing: Royalties/Patent (Ongoing); Mainstay Medical: Consulting/Advisory Board (Terminated); SPR Therapeutics: Funded Research (Institution) (Terminated)
“Regenerative Medicine” and Mechanism of Action: Time for a New Title?
Thursday, November 21, 2024
10:45 AM - 11:00 AM PT
Disclosure(s): Bull Publishing: Royalties/Patent (Ongoing); Mainstay Medical: Consulting/Advisory Board (Terminated); SPR Therapeutics: Funded Research (Institution) (Terminated)
Long-term Functional Outcomes: Mitigating Potential Complications
Thursday, November 21, 2024
4:30 PM - 4:45 PM PT
Disclosure(s): Bull Publishing: Royalties/Patent (Ongoing); Mainstay Medical: Consulting/Advisory Board (Terminated); SPR Therapeutics: Funded Research (Institution) (Terminated)
WS-11 - Regenerative Medicine, Prolotherapy, Tenotomy
Friday, November 22, 2024
8:00 AM - 12:15 PM PT
Disclosure(s): Bull Publishing: Royalties/Patent (Ongoing); Mainstay Medical: Consulting/Advisory Board (Terminated); SPR Therapeutics: Funded Research (Institution) (Terminated)
Foundations of Low Back Pain: What Leads to Functional Disability?
Friday, November 22, 2024
4:25 PM - 4:40 PM PT
Disclosure(s): Bull Publishing: Royalties/Patent (Ongoing); Mainstay Medical: Consulting/Advisory Board (Terminated); SPR Therapeutics: Funded Research (Institution) (Terminated)